The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...

Dr. Tim Rittman, a neurology consultant, highlights lesser-known early symptoms of dementia such as mild forgetfulness, ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

When it comes to healthcare, having access to reliable medical facilities is essential. Ajman is home to several top-tier ...

The  American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and ...

While your risk of dementia does go up with age, around 40 per cent of cases could actually be prevented by making certain ...